Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00158639 · ClinicalTrials.gov registry record · Phase 3
Electronic Communications and Home Blood Pressure Monitoring
A Phase 3 study of Hypertension, sponsored by Kaiser Permanente.
- Completed
- Registry status
- Phase 3
- Development phase
- 778
- Enrollment target
- 1
- Study location
NCT00158639 is a Phase 3 study of Hypertension that has completed, run by Kaiser Permanente. The registered enrollment target is 778 participants, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00158639, a Phase 3 study of Hypertension, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 778 participants
- Enrollment target
- 1
- Study location
Study Summary
The control of blood pressure (BP) for patients with hypertension on medications has been elusive, despite the availability of evidence-based nationally recognized guidelines for treatment and 30 years of research addressing this. At present, less than 50% of patients with known hypertension are adequately controlled. If BP control could be improved, significant decreases in cardiovascular morbidity and mortality would occur. The purpose of this study is to conduct a randomized controlled trial of the effectiveness of the provision of home blood pressure measurement and electronic communications (secure messaging to health care providers) to improve hypertension control.
Conditions Studied
Interventions
- BEHAVIORAL Home BP;secure messaging;pharmaceutical care;
Study Locations (1)
Washington
- Group Health Research Institute - Seattle
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 778 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-12 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00158639
The ClinicalTrials.gov registry entry for NCT00158639 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 778 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,506-participant average among 470 other Hypertension trials with a reported enrollment target (78% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Home BP;secure messaging;pharmaceutical care; is the first listed.
NCT00158639 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.
Frequently Asked Questions
What is clinical trial NCT00158639 about?
NCT00158639 is a clinical study titled "Electronic Communications and Home Blood Pressure Monitoring". The control of blood pressure (BP) for patients with hypertension on medications has been elusive, despite the availability of evidence-based nationally recognized guidelines for treatment and 30 years of research addressing this. At present, less than 50% of patients with known hypertension are ade...
What is the current status of trial NCT00158639?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 778 participants. The study started on 2005-06. Estimated completion is 2007-12.
What conditions does trial NCT00158639 study?
This clinical trial studies the following conditions: Hypertension.
What interventions are being tested in trial NCT00158639?
The interventions under investigation include: Home BP;secure messaging;pharmaceutical care; (BEHAVIORAL).
Who is sponsoring clinical trial NCT00158639?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00158639 being conducted?
This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
RECRUITING · Phase 3
-
Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR)
RECRUITING · Phase 3
-
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL1
RECRUITING · Phase 3
-
Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
RECRUITING · Phase 3
-
A Master Protocol for Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight: (ATTAIN-Hypertension Screening)
RECRUITING · Phase 3
-
A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.